Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation

International Journal of Molecular Medicine

Volumn 30, Issue 5, 2012, Pages 1211-1218

  Park, Seung Bin ^a   Bae, Jong Woon ^a   Kim, Jong Min ^a   Lee, Seung Gee ^a   Han, Myoungseok ^a  

^a Dong A University   (South Korea)

Author keywords

Endometrial carcinoma; Epigallocatechin 3 gallate; Estrogen receptor; Progesterone receptor

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE; CYCLINE; EPIGALLOCATECHIN GALLATE; ESTRADIOL; ESTRADIOL RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ENZYME ACTIVATION; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; HUMANS; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84866607823     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1104     Document Type: Article

References (29)

1. Doll A, Abal M, Rigau M, et al: Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108: 221-229, 2008.
2. Albrektsen G, Heuch I, Tretli S and Kvale G: Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 Norwegian women. Int J Cancer 61: 485-490, 1995.
3. Kalandidi A, Tzonou A, Lipworth L, Gamatsi I, Filippa D and Trichopoulos D: A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology 53: 354-359, 1996.
4. Grady D, Gebretsadik T, Kerlikowske K, Ernster V and Petitti D: Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85: 304-313, 1995.
5. Akhmedkhanov A, Zeleniuch-Jacquotte A and Toniolo P: Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann NY Acad Sci 943: 296-315, 2001.
6. Holinka CF, Anzai Y, Hata H, Kimmel N, Kuramoto H and Gurpide E: Proliferation and responsiveness to estrogen of human endometrial cancer cells under serum-free culture conditions. Cancer Res 49: 3297-3301, 1989.
7. Bouskine A, Nebout M, Mograbi B, Brucker-Davis F, Roger C and Fenichel P: Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A. Endocrinology 149: 565-573, 2008.
8. Castoria G, Migliaccio A, Bilancio A, et al: PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20: 6050-6059, 2001.
9. Robertson JA, Farnell Y, Lindahl LS and Ing NH: Estradiol up-regulates estrogen receptor messenger ribonucleic acid in endometrial carcinoma (Ishikawa) cells by stabilizing the message. J Mol Endocrinol 29: 125-135, 2002.
10. Cheskis BJ, Greger J, Cooch N, et al: MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways. Steroids 73: 901-905, 2008.
11. Wolpin BM and Mayer RJ: Systemic treatment of colorectal cancer. Gastroenterology 134: 1296-1310, 2008.
12. Fujiki H, Suganuma M, Okabe S, et al: Japanese green tea as a cancer preventive in humans. Nutr Rev 54: S67-S70, 1996.
13. Pan MH, Chiou YS, Wang YJ, Ho CT and Lin JK: Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate. Food Funct 2: 101-110, 2011.
14. Webb T: Green tea experiments in lab, clinic yield mixed results. J Natl Cancer Inst 92: 1038-1039, 2000.
15. Cao Y and Cao R: Angiogenesis inhibited by drinking tea. Nature 398: 381, 1999.
16. Yokoyama M, Noguchi M, Nakao Y, Pater A and Iwasaka T: The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol Oncol 92: 197-204, 2004.
17. Zhang G, Gurtu V, Kain SR and Yan G: Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 23: 525-531, 1997.
18. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
19. Beral V, Bull D and Reeves G: Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365: 1543-1551, 2005.
20. Lovely LP, Appa Rao KB, Gui Y and Lessey BA: Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem Mol Biol 74: 235-241, 2000.
21. Snijders MP, de Goeij AF, Debets-Te Baerts MJ, Rousch MJ, Koudstaal J and Bosman FT: Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil 94: 363-371, 1992.
22. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L and Weinstein IB: (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 11: 2735-2746, 2005.
23. Khan N, Afaq F, Saleem M, Ahmad N and Mukhtar H: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin- 3-gallate. Cancer Res 66: 2500-2505, 2006.
24. Ahmad N, Feyes DK, Nieminen AL, Agarwal R and Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89: 1881-1886, 1997.
25. Yang CS, Maliakal P and Meng X: Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42: 25-54, 2002.
26. Ahmad N, Cheng P and Mukhtar H: Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 275: 328-334, 2000.
27. Liu X, Zhang DY, Zhang W, Zhao X, Yuan C and Ye F: The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma. Nutr Cancer 63: 466-475, 2011.
28. Ahn WS, Yoo J, Huh SW, et al: Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 12: 383-390, 2003.
29. Jatoi A, Ellison N, Burch PA, et al: A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97: 1442-1446, 2003.